Lv1
18 积分 2025-07-06 加入
FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
1天前
已完结
Beyond intestinal soap—bile acids in metabolic control
1个月前
已完结
Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway
1个月前
已完结
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
1个月前
已完结
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
1个月前
已完结
Current status and future trends of the global burden of MASLD
1个月前
已完结
High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice
1个月前
已完结
Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice
3个月前
已完结
Dual Modulator of FXR and HSD17B13: Revitalizing FXR Therapies in MASH
3个月前
已完结
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
3个月前
已完结
皖公网安备34019202002308
